logo

For the Inventor, By the Inventor

New York, NY, United States of America

Roman Perez-Soler

This inventor holds 29 USPTO granted patents and 4 published patent applications and 2 EPO patents, primarily in Cancer Treatment. Top assignees: The University of Texas System, Houston Pharmaceuticals, Inc., Albert Einstein College of Medicine. Active years: 1989-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roman Perez-Soler. Retrieved from https://idiyas.com/inventor/roman-perez-soler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 29 

% Patents Active = 75.9


Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 483(Granted Patents)


Location History:

  • Harris, TX (US) (1991 - 1993)
  • Setauket, NY (US) (2003)
  • Houston, TX (US) (1989 - 2007)
  • New York, NY (US) (2002 - 2015)

Company Filing History:

goldMedal15 out of 5,640 
 
The University of Texas System
 patents
silverMedal3 out of 3 
 
Houston Pharmaceuticals, Inc.
 patents
bronzeMedal2 out of 514 
 
Albert Einstein College of Medicine
 patents
4. 1 out of 12 
 
Aronex Pharmaceuticals, Inc.
 patents
5. 1 out of 67 
 
Insmed Incorporated
 patents
6. 8 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1989-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Cancer Treatment
Lipid-Based Formulations
Anthracycline Antibiotics
Gene Therapy
Liposome Suspensions
Platinum Compounds
Chemosensitivity Screening
Topoisomerase Inhibitors
Carotenoids
Halogenated Sugars
Doxorubicin Resistance
29 patents (USPTO):Explore Patents
1. 9107824 - Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally (2015-08-18),
2. 8283382 - Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy (2012-10-09),
3. 7745494 - Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy (2010-06-29),
4. 7557090 - Anthracycline antibiotics and methods of treating cancer using the same (2009-07-07),
5. 7238366 - Submicron liposome suspensions obtained from preliposome lyophilizates (2007-07-03),
6. 7157098 - Gene therapy of tumors using non-viral delivery system (2007-01-02),
7. 7109177 - Methods and compositions for the manufacture of C-3' and C-4′ anthracycline antibiotics (2006-09-19),
8. 7029696 - Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes (2006-04-18),
9. 6696079 - Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes (2004-02-24),
10. 6680300 - Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents (2004-01-20),
11. 6673907 - Methods and compositions for the manufacture of C-3′ and C-4′ anthracycline antibiotics (2004-01-06),
12. 6620403 - In vivo chemosensitivity screen for human tumors (2003-09-16),
13. 6527765 - Cryogenic surgical system and method of use in removal of tissue (2003-03-04),
14. 6437105 - Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents (2002-08-20),
15. 6355784 - Methods and compositions for the manufacture of halogenated anthracyclines with increased antitumor activity, other anthracyclines, halogenated sugars, and glycosyl donors (2002-03-12),

Title: Roman Perez-Soler - Innovative Inventor from New York

Introduction: Roman Perez-Soler is a renowned inventor based in New York, known for his groundbreaking contributions to the field of medical technology.

Latest Patents: Roman Perez-Soler holds several patents in the medical device industry, focusing on advancements in cancer treatment and diagnostic tools.

Career Highlights: With a career spanning over two decades, Perez-Soler has worked tirelessly to develop cutting-edge solutions for improving patient outcomes in oncology.

Collaborations: Throughout his career, Roman Perez-Soler has collaborated with leading research institutions and pharmaceutical companies to bring his inventions to life and make a meaningful impact in the healthcare sector.

Conclusion: Roman Perez-Soler's dedication to innovation and his passion for improving cancer care have solidified his reputation as a pioneering inventor in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…